Torrent Pharmaceuticals Limited
TORNTPHARM.NS
₹4941.50
▼ 1.41%
Torrent Pharmaceuticals dipped 1.41% to Rs 4,941.50, pulling back modestly with no specific news driving the move. The stock nonetheless remains one of the stronger performers in the pharma space over the long run, clocking a 36.95% CAGR over the past year and a 25.35% CAGR over five years, alongside a healthy near-20% return over the past decade. Reflecting that consistency, 29 analysts have arrived at a buy consensus with an average target of Rs 5,386.76, indicating room above current levels even after today's dip.
CAGR Performance
| 1 Year | 2 Years | 5 Years | 10 Years |
|---|---|---|---|
| 34.75% | 18.35% | 24.88% | 19.52% |
Analyst Consensus
Average Target Price: ₹5386.76 (range ₹4150.00 - ₹6194.00) based on 29 analysts
Strong Buy: 7
Buy: 16
Hold: 5
Sell: 0
Strong Sell: 1
Related News
| May 5, 2026 | Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma |
No comments:
Post a Comment